The Cancer Detection Panel for Men is a comprehensive diagnostic screening designed to identify potential cancer biomarkers and early-stage malignancies specific to male health.
This multi-test panel typically evaluates key tumor markers such as PSA (Prostate-Specific Antigen) for prostate health, along with blood tests for gastrointestinal, liver, and lung indicators like CEA and AFP. By assessing these biological red flags, the panel helps physicians catch abnormalities before symptoms arise. It is an invaluable preventative tool for proactive health management, enabling early intervention, more effective treatment options, and significantly improved long-term survival outcomes for men.